Kaplan-Meier survival analysis: influence of early urological complications following KTX on graft and patient survival. (A) Graft survival, deceased-donor KTX recipients (log-rank test 0.034, p=0.853); (B) Graft survival, living-donor KTX recipients (log-rank test 0.163, p=0.686); (C) Patient survival, deceased-donor KTX recipients (log-rank test 0.435, p=0.510); (D) Patient survival, living-donor KTX recipients (log-rank test 0.414, p=0.520).